ID27788A - TUMOR ANTIGENAL PEPTIDES OBTAINED FROM CYCLEFILIN B - Google Patents

TUMOR ANTIGENAL PEPTIDES OBTAINED FROM CYCLEFILIN B

Info

Publication number
ID27788A
ID27788A IDW20002735A ID20002735A ID27788A ID 27788 A ID27788 A ID 27788A ID W20002735 A IDW20002735 A ID W20002735A ID 20002735 A ID20002735 A ID 20002735A ID 27788 A ID27788 A ID 27788A
Authority
ID
Indonesia
Prior art keywords
cyclophilins
tumor
cyclefilin
antigenal
derivatives
Prior art date
Application number
IDW20002735A
Other languages
Indonesian (id)
Inventor
Kyogo Itoh
Shinya Gomi
Original Assignee
Kyogo Itoh Cs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyogo Itoh Cs filed Critical Kyogo Itoh Cs
Publication of ID27788A publication Critical patent/ID27788A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Tumor antigen peptides derived from cyclophilins or derivatives thereof having the functionally equivalent properties; medicaments, prophylactics, or diagnostics for tumors comprising as an active ingredient such tumor antigen peptides or derivatives thereof, cyclophilins or partial polypeptides thereof, or genes encoding said cyclophilins or partial polypeptides thereof; in vitro use of the above substances for treatment of tumors; and antibodies against the above tumor antigen peptides derived from cyclophilins or derivatives thereof are provided.
IDW20002735A 1998-06-25 1999-06-24 TUMOR ANTIGENAL PEPTIDES OBTAINED FROM CYCLEFILIN B ID27788A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17844998 1998-06-25

Publications (1)

Publication Number Publication Date
ID27788A true ID27788A (en) 2001-04-26

Family

ID=16048723

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002735A ID27788A (en) 1998-06-25 1999-06-24 TUMOR ANTIGENAL PEPTIDES OBTAINED FROM CYCLEFILIN B

Country Status (15)

Country Link
US (2) US7041297B1 (en)
EP (1) EP1090924B8 (en)
JP (1) JP4413429B2 (en)
KR (1) KR100653590B1 (en)
CN (1) CN1318447C (en)
AT (1) ATE375362T1 (en)
AU (1) AU749544B2 (en)
CA (1) CA2331761A1 (en)
DE (1) DE69937294T2 (en)
ES (1) ES2294844T3 (en)
HK (1) HK1067645A1 (en)
ID (1) ID27788A (en)
NZ (1) NZ508996A (en)
TW (1) TWI228128B (en)
WO (1) WO1999067288A1 (en)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105306B1 (en) * 2000-08-10 2006-09-12 Trustees Of The University Of Pennsylvania Methods and compositions for modulating somatolactogenic functions
EP1212078B1 (en) * 1999-09-10 2005-06-22 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Ant-1 as drug target
US6833365B2 (en) * 2000-01-24 2004-12-21 Trustees Of Tufts College Tetracycline compounds for treatment of Cryptosporidium parvum related disorders
DE60102815D1 (en) * 2000-05-15 2004-05-19 Paratek Pharm Innc 7-SUBSTITUTED CONDENSED RING TETRAZYCLINE COMPOUNDS
AU2001268475A1 (en) * 2000-06-16 2002-01-02 Trustees Of Tufts College 7-phenyl-substituted tetracycline compounds
WO2003055441A2 (en) * 2001-08-02 2003-07-10 Paratek Pharmaceuticals, Inc. Medicaments
DK2267021T3 (en) 2002-09-12 2015-03-30 Oncotherapy Science Inc KDR peptides and vaccines comprising the same
CA2538300A1 (en) * 2003-09-22 2005-03-31 Green Peptide Co., Ltd. Prognosis in cancer patients vaccinated with a cancer antigen peptide-associated agent
TWI261038B (en) * 2004-08-11 2006-09-01 Bo-Cheng Chen Bicycle gear-shifting handgrip
EP2301916A3 (en) 2004-10-25 2011-09-28 Paratek Pharmaceuticals, Inc. 4-aminotetracyclines and methods of use thereof
AU2007244153C1 (en) 2006-05-01 2011-09-29 Hitachi Chemical Company, Ltd. Prostasin partial peptide and anti-prostasin antibody
WO2008045507A2 (en) 2006-10-11 2008-04-17 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of bacillus anthracis infections
TW200831673A (en) 2006-12-13 2008-08-01 Oncotherapy Science Inc TTK as tumor marker and therapeutic target for lung cancer
JP5470558B2 (en) 2007-02-16 2014-04-16 オンコセラピー・サイエンス株式会社 Choroidal neovascularization vaccine therapy
TWI434853B (en) 2007-04-11 2014-04-21 Oncotherapy Science Inc Tem8 peptides and vaccines comprising the same
US20110160280A1 (en) 2007-08-24 2011-06-30 Oncotherapy Science, Inc. Cancer-related genes, cdca5, epha7, stk31 and wdhd1
CN101854945B (en) 2007-09-18 2015-07-01 株式会社绿多肽 Ctl inducer composition
ES2388958T3 (en) 2007-11-29 2012-10-22 Actelion Pharmaceuticals Ltd. Phosphonic acid derivatives and their use as a P2Y12 receptor antagonist
TWI526219B (en) 2008-06-19 2016-03-21 腫瘤療法 科學股份有限公司 Cdca1 epitope peptides and vaccines containing the same
DE102008060549A1 (en) 2008-12-04 2010-06-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Drug-peptide construct for extracellular accumulation
TWI500932B (en) 2008-12-05 2015-09-21 Oncotherapy Science Inc Wdrpuh epitope peptides and vaccines containing the same
TWI469791B (en) 2009-02-18 2015-01-21 Oncotherapy Science Inc Foxm1 peptides and vaccines containing the same
CN102356155B (en) 2009-03-18 2016-02-24 肿瘤疗法科学股份有限公司 NEIL3 peptide and comprise its vaccine
TWI507204B (en) 2009-05-26 2015-11-11 Oncotherapy Science Inc Cdc45l peptides and vaccines including the same
TW201136604A (en) 2009-12-14 2011-11-01 Oncotherapy Science Inc TMEM22 peptides and vaccines including the same
RU2570560C2 (en) 2010-03-11 2015-12-10 Онкотерапи Сайенс, Инк. Hjurp peptides and vaccines containing them
WO2013018690A1 (en) 2011-07-29 2013-02-07 国立大学法人徳島大学 Erap1-derived peptide and use thereof
US9458447B2 (en) 2011-08-12 2016-10-04 Oncotherapy Science, Inc. MPHOSPH1 peptides and vaccines including the same
BR112014009176B1 (en) 2011-10-28 2022-08-30 Oncotherapy Science, Inc COMPOSITION FOR INDUCTION OF CYTOTOXIC T-LYMPHOCYTE (CTL), USE IN THE TREATMENT AND PROPHYLAXIS OF CANCER AND INDUCTION OF IMMUNE RESPONSE AGAINST CANCER AND IN VITRO METHODS FOR INDUCTION OF CTL
US9561265B2 (en) 2012-07-10 2017-02-07 Oncotherapy Science, Inc. KIF20A epitope peptides for TH1 cells and vaccines containing the same
JP6255594B2 (en) 2012-07-10 2018-01-10 オンコセラピー・サイエンス株式会社 LY6K epitope peptide of Th1 cell and vaccine containing the same
WO2014041784A1 (en) 2012-09-11 2014-03-20 Oncotherapy Science, Inc. Ube2t peptides and vaccines containing the same
TWI658049B (en) 2013-03-12 2019-05-01 腫瘤療法 科學股份有限公司 Kntc2 peptides and vaccines containing the same
SG11201603165TA (en) 2013-10-21 2016-05-30 Taiho Pharmaceutical Co Ltd Novel Peptide Having 4 Linked CTL Epitopes
MX2017001650A (en) 2014-08-04 2017-04-27 Oncotherapy Science Inc Cdca1-derived peptide and vaccine containing same.
CN111925413A (en) 2014-08-04 2020-11-13 肿瘤疗法科学股份有限公司 KOC 1-derived peptides and vaccines containing the same
ES2856834T3 (en) 2014-08-04 2021-09-28 Oncotherapy Science Inc URLC10 derived peptide and vaccine containing the same
EP4219525A3 (en) 2015-10-08 2023-09-27 OncoTherapy Science, Inc. Foxm1-derived peptide, and vaccine including same
KR20240099456A (en) 2018-06-29 2024-06-28 다이호야쿠힌고교 가부시키가이샤 Antitumor agent and evaluation method thereof
TW202023581A (en) 2018-08-02 2020-07-01 日商腫瘤療法 科學股份有限公司 Cdca1-derived peptide and vaccine containing same
JP7525855B2 (en) 2018-11-30 2024-07-31 国立大学法人徳島大学 Breast cancer therapeutic agent containing PHB2-derived peptide that inhibits BIG3-PHB2 interaction
AU2020411439A1 (en) 2019-12-26 2022-08-04 Taiho Pharmaceutical Co., Ltd. Agent for adjuvant therapy
CN115078727A (en) * 2022-07-13 2022-09-20 首都医科大学附属北京胸科医院 Marker for predicting cancer immunotherapy effect, kit and application
DE102022118517A1 (en) 2022-07-25 2024-01-25 Dennis Reitmeir Push-up device with rotating handle units
CN115372618A (en) * 2022-09-19 2022-11-22 首都医科大学附属北京胸科医院 Application of reagent for detecting protein marker level in preparation of diagnostic product for evaluating tumor treatment effect

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0326067A3 (en) 1988-01-26 1991-04-17 The Du Pont Merck Pharmaceutical Company Use of cyclophilin as an anti-inflammatory and immunomodulatory agent
AU4998993A (en) 1992-08-07 1994-03-03 Epimmune, Inc. Hla binding peptides and their uses
JPH09151200A (en) * 1995-09-29 1997-06-10 Ajinomoto Co Inc Peptide capable of inducing immune response to human gastric cancer, therapeutic and preventive agent for human gastric cancer containing the same
US5840839A (en) * 1996-02-09 1998-11-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein

Also Published As

Publication number Publication date
AU749544B2 (en) 2002-06-27
ATE375362T1 (en) 2007-10-15
US7368107B2 (en) 2008-05-06
DE69937294D1 (en) 2007-11-22
KR100653590B1 (en) 2006-12-04
NZ508996A (en) 2003-09-26
EP1090924A4 (en) 2002-07-10
CN1525980A (en) 2004-09-01
EP1090924A1 (en) 2001-04-11
KR20010053180A (en) 2001-06-25
AU4392699A (en) 2000-01-10
CA2331761A1 (en) 1999-12-29
DE69937294T2 (en) 2008-07-03
HK1067645A1 (en) 2005-04-15
EP1090924B1 (en) 2007-10-10
ES2294844T3 (en) 2008-04-01
TWI228128B (en) 2005-02-21
EP1090924B8 (en) 2007-11-21
WO1999067288A9 (en) 2000-03-30
WO1999067288A1 (en) 1999-12-29
CN1318447C (en) 2007-05-30
JP4413429B2 (en) 2010-02-10
US20060008463A1 (en) 2006-01-12
US7041297B1 (en) 2006-05-09

Similar Documents

Publication Publication Date Title
ID27788A (en) TUMOR ANTIGENAL PEPTIDES OBTAINED FROM CYCLEFILIN B
EP2022800A3 (en) Compositions for the therapy and diagnosis of ovarian cancer
ATE397621T1 (en) INHIBITORS OF INTERACTION BETWEEN P53 AND MDM2
IL125590A (en) Peptide immunogens, process for their preparation and use thereof as vaccines against allergies
BR9907259A (en) Compounds for therapy and diagnosis of lung cancer and processes for their use
NZ516381A (en) Lung tumor proteins in the therapy and diagnosis of lung cancer
AU2001235006A1 (en) Prophylactic and therapeutic monoclonal antibodies
DE60239707D1 (en) ANTIMICROBIAL CATIONIC PEPTIDES AND FORMULATIONS CONTAINING THEM
WO1999033869A3 (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
WO1997018790A3 (en) Therapeutic and diagnostic agents for the treatment of microbial infections
WO2000061756A3 (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
EP1762620A3 (en) Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof
NZ510154A (en) A tumour antigen protein and gene therefor, tumour antigen peptides and derivatives thereof in medicaments and prophylactics
EP1364657A4 (en) Remedies for tumor in hematopoietic organs
WO2003004517A3 (en) Peyers's patch and/or m-celle targeting ligands
NZ331398A (en) Tumor rejection antigens presented by hla-b44 molecules, and uses thereof
WO2004047757A3 (en) Diagnosing and treating hematopoietic cancers
WO2001029220A3 (en) Mage-a12 antigenic peptides and uses thereof
DE50114335D1 (en) LH-RH ANTAGONISTS, THEIR PREPARATION AND THEIR USE AS DRUGS
WO2002066492A3 (en) Human adrenomedullin-specific antibody, pharmaceutical composition containing same, therapeutic uses thereof
ID27162A (en) HLA-A2 ANTIGENT TUMOR PEPTIDES LIMITED FROM SART-1
CY1108790T1 (en) COMPOSITIONS FOR TREATMENT AND DIAGNOSIS OF OVARIAN CANCER
WO2002100346A3 (en) (r, r'),(r',s')-amphetaminil, compositions and uses thereof
WO2002100342A3 (en) (s, s'), (s, r')-amphetaminil, compositions and uses thereof
EP2003201A3 (en) Compounds and methods for therapy and diagnosis of lung cancer